Trimph is a portfolio company of ATP Innovations
ATP Innovations warmly welcomes new client company Trimph. A deep tech biomedical company, Trimph is commercialising injectable medical device technology that accelerates the natural regeneration of cartilage, bone, and interface tissue for medical, surgical, prosthodontics and cosmetic applications.
For more information about Trimph, visit www.trimph.com.au.
Trimph is a portfolio company of ATP Innovations, Australia’s leading advanced technology business incubator.